Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study.
Shih-Lung ChengMing-Lin HoYun-Fa LaiHao-Chien WangJeng-Yuan HsuShih-Feng LiuMing-Shyang HuangCheng-Hung LeeChing-Hsiung LinLiang-Wen HangYu-Chih LiuKuang-Yao YangJia-Horng WangPublished in: Drug design, development and therapy (2020)
ClinicalTrials.gov registration number: NCT00784953.